Abstract: Dihydrochalcomycin (1) and chalcomycin (2), two known chalcomycins, and chalcomycin E (3), a new compound, were isolated from marine-derived Streptomyces sp. HK-2006-1. Their structures were elucidated by detailed spectroscopic and X-ray crystallographic analysis. The antimicrobial activities against Staphylococcus aureus, Escherichia coli, Candida albicans, and Aspergillus niger of 1-3 were evaluated. Compounds 1-2 exhibited activities against S. aureus with minimal inhibitory concentrations (MICs) of 32 µg/mL and 4 µg/mL, respectively. The fact that 1-2 showed stronger activity against S. aureus 209P than 3 indicated that the epoxy unit was important for antimicrobial activity. This structure-activity tendency of chalcomycins against S. aureus is different from that of aldgamycins reported in our previous research, which provide a valuable example for the phenomenon that 16-membered macrolides with different sugars do not have parallel structure-activity relationships.
Introduction
Infectious diseases seriously imperil human health. Antibiotics are important medicines against infectious diseases [1] . However, the prolonged, extensive, and indiscriminate use of antibiotics has triggered widespread resistance [2] . The global epidemic of continually rising resistance has become a critical threat to human health and therefore the discovery of new antibiotics is urgently needed [2] . Macrolide antibiotics such as erythromycins, tylosins, avermectins, and milbemycins have significant activity against a broad spectrum of Gram-positive bacteria [3] [4] [5] , playing an important role in the chemotherapy of infectious diseases [6, 7] . Macrolides are usually characterized by a 12-, 14-, 16-, 18-, 20-, 22-, or 24-membered lactone ring with one or more sugar moieties [3, 8] . Different types of macrolides have different structure-antimicrobial activity relationships. For example, 16-membered macrolides with different sugars have no parallel structure-activity tendencies. Omura reported that the structure-activity relationships of some 16-membered macrolides (rosamicins, angolamycins, and neutramycins) differed from the evidence found in other 16-membered macrolides (leucomycins) [9] . The 16-membered macrolides with different sugar moiety for instance spiramycins, neospiramycins, and forocidins have different structure-activity relationships [10] .
Many interesting strains were obtained in our continuing investigations on active components from microorganisms. Among our recent discoveries [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , we recently reported that a strain of Streptomyces sp. HK-2006-1 produced both aldgamycins and chalcomycins, which are 16-membered macrolides [11, 21] . Chalcomycin and seven aldgamycins were isolated from this strain, and chalcomycin showed more potent antibacteria activity against Staphylococcus aureus than aldgamycins [11] . Chalcomycin, the first member of chalcomycins, was reported with its activity against bacteria as early as 1962 [22] . However, there have only been seven chalcomycins (chalcomycin, chalcomycins B-D, dihydrochalcomycin, 8-deoxy-chalcomycin, 250-144C) reported until now [23] [24] [25] [26] [27] , and there is no discussion on the structure-antimicrobial activity relationship of chalcomycins against S. aureus. Thus, in this study, the fermentation volume of this strain Streptomyces sp. HK-2006-1 was scaled up in search of more chalcomycins. The crude extract of the culture of the strain was subjected to column chromatography (CC) over silica gel, Sephadex LH-20, octadecylsilane (ODS), and high performance liquid chromatography (HPLC), yielding three chalcomycins, dihydrochalcomycin (1), chalcomycin (2) , and a new compound, chalcomycin E (3) (Figure 1 ). In addition, their antimicrobial activities against two bacteria, Gram-positive S. aureus 209P and Gram-negative Escherichia coli ATCC0111, as well as two fungi, Candida albicans FIM709 and Aspergillus niger R330, were evaluated. Details of the isolation, structural elucidation, and antimicrobial activities of compounds 1-3 are presented herein. and neutramycins) differed from the evidence found in other 16-membered macrolides (leucomycins) [9] . The 16-membered macrolides with different sugar moiety for instance spiramycins, neospiramycins, and forocidins have different structure-activity relationships [10] . Many interesting strains were obtained in our continuing investigations on active components from microorganisms. Among our recent discoveries [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , we recently reported that a strain of Streptomyces sp. HK-2006-1 produced both aldgamycins and chalcomycins, which are 16-membered macrolides [11, 21] . Chalcomycin and seven aldgamycins were isolated from this strain, and chalcomycin showed more potent antibacteria activity against Staphylococcus aureus than aldgamycins [11] . Chalcomycin, the first member of chalcomycins, was reported with its activity against bacteria as early as 1962 [22] . However, there have only been seven chalcomycins (chalcomycin, chalcomycins B-D, dihydrochalcomycin, 8-deoxy-chalcomycin, 250-144C) reported until now [23] [24] [25] [26] [27] , and there is no discussion on the structure-antimicrobial activity relationship of chalcomycins against S. aureus. Thus, in this study, the fermentation volume of this strain Streptomyces sp. HK-2006-1 was scaled up in search of more chalcomycins. The crude extract of the culture of the strain was subjected to column chromatography (CC) over silica gel, Sephadex LH-20, octadecylsilane (ODS), and high performance liquid chromatography (HPLC), yielding three chalcomycins, dihydrochalcomycin (1), chalcomycin (2) , and a new compound, chalcomycin E (3) (Figure 1 ). In addition, their antimicrobial activities against two bacteria, Gram-positive S. aureus 209P and Gram-negative Escherichia coli ATCC0111, as well as two fungi, Candida albicans FIM709 and Aspergillus niger R330, were evaluated. Details of the isolation, structural elucidation, and antimicrobial activities of compounds 1-3 are presented herein. 
Results and Discussion
Compounds 1 and 2 were established as dihydrochalcomycin and chalcomycin respectively by precisely comparing the nuclear magnetic resonance (NMR) data with literature values [11, 24, 28] . The single-crystal X-ray crystallographic analysis of dihydrochalcomycin (1) 
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Compounds 1 and 2 were established as dihydrochalcomycin and chalcomycin respectively by precisely comparing the nuclear magnetic resonance (NMR) data with literature values [11, 24, 28] . The single-crystal X-ray crystallographic analysis of dihydrochalcomycin (1) was reported for the first time (Figure 2 ). Chalcomycin (2) was also obtained and identified in our previous study on the strain of Streptomyces sp. HK-2006-1 [11] . Compound 3 was obtained as a white amorphous powder. The quasi-molecular ion at m/z 707.3616 [M + Na] + by high resolution electrospray ionization mass spectroscopy (HRESIMS) indicated that the molecular formula of 3 was C 35 H 56 O 13 (eight degrees of unsaturation), which was 16 atomic mass unit (O) less than 2. Analysis of its 1 H and 13 C NMR spectroscopic data (Table 1) revealed nearly identical structure features to 2, except that two mono-oxygenated methine carbons at δ C 59.0 and 58.7 disappeared, and two olefinic carbons at δ C 143.3 and 133.0 appeared. Analysis of 1 H− 1 H COSY and the coupling values of the protons revealed the presence of the spin system C-10−C-11−C-12−C-13−C-14(C-20)−C-15−C-16. Therefore, 3 was the reduction product of 2 at C-12/C-13. The geometrical configuration of the double bond moiety (C-12/C-13) was deduced as E on the basis of the coupling constant of the olefinic protons (J 12,13 = 14.1 Hz). Thus, compound 3 can be recognized as a new member of the chalcomycin family, consisting of the 16-membered lactone ring, mycinose, and chalcose, and its structure was further confirmed by two-dimensional NMR (2D NMR) data (Table 1 and Table S1 ). The observed rotating frame overhauser effect spectroscopy (ROESY) correlations ( Figure 3) were consistent with the stereochemistry of the 16-membered lactone ring. All the reported mycinose and chalcose units in natural products have D configurations. The mycinose and chalcose units in the isolated macrolides from the strain of Streptomycetes sp. HK-2006-1 also had D configurations [11] . Therefore, the absolute configurations of the mycinose and chalcose units in 3 were assumed to be D. The relative configurations of the two units were established as β from the coupling constants of the anomeric protons (H-1 and H-1 ). Thus, the structure of 3 was elucidated as (3E,5S,6S,7S,9S,11E,13E,15R,16R)-9-hydroxy-15-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)-6-((2S,3R,4S,6R)-3-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,7,9,16-tetramethyloxacyclohexadeca-3,11,13-triene-2,10-dione, and named as chalcomycin E. Until now, only seven chalcomycins had been reported. The discovery of chalcomycin E (3) adds a new member to chalcomycins. The single-crystal X-ray crystallographic analysis of dihydrochalcomycin (1) was firstly reported. Compounds 1-3 were tested for antimicrobial activities against two bacteria, Gram-positive S. aureus 209P and Gram-negative E. coli ATCC0111, as well as two fungi, C. albicans FIM709 and A. niger R330 ( Table 2 ). Compounds 1-2 showed activities against S. aureus, but no activity against the other test strains. The fact that 1 and 2 exhibited stronger activity against S. aureus 209P than 3 suggested that the epoxy unit was important for antimicrobial activity. However, the replacement of the double bond in C-10 to C-13 by the epoxy unit in aldgamycins is not beneficial for antimicrobial activity. The difference in structure between aldgamycins and chalcomycins is just the sugar type at C-5, but the two types of macrolides have different structureactivity tendencies. Our findings provide a valuable example for the phenomenon that 16-membered macrolide antibiotics with different sugars do not have parallel structure-activity relationships [9, 10] . Until now, only seven chalcomycins had been reported. The discovery of chalcomycin E (3) adds a new member to chalcomycins. The single-crystal X-ray crystallographic analysis of dihydrochalcomycin (1) was firstly reported. Compounds 1-3 were tested for antimicrobial activities against two bacteria, Gram-positive S. aureus 209P and Gram-negative E. coli ATCC0111, as well as two fungi, C. albicans FIM709 and A. niger R330 ( Table 2 ). Compounds 1-2 showed activities against S. aureus, but no activity against the other test strains. The fact that 1 and 2 exhibited stronger activity against S. aureus 209P than 3 suggested that the epoxy unit was important for antimicrobial activity. However, the replacement of the double bond in C-10 to C-13 by the epoxy unit in aldgamycins is not beneficial for antimicrobial activity. The difference in structure between aldgamycins and chalcomycins is just the sugar type at C-5, but the two types of macrolides have different structure-activity tendencies. Our findings provide a valuable example for the phenomenon that 16-membered macrolide antibiotics with different sugars do not have parallel structure-activity relationships [9, 10] . 
Conclusions
Two known chalcomycins, dihydrochalcomycin (1) and chalcomycin (2), together with a new one, chalcomycin E (3) were isolated from marine-derived Streptomyces sp. HK-2006-1. Their structures were determined by detailed spectroscopic and X-ray crystallographic analysis. The discovery of chalcomycin E (3) adds a new member to chalcomycins. The antimicrobial activities of 1-3 were tested against S. aureus, E. coli, C. albicans, and A. niger. Compounds 1-2 showed activities against S. aureus with minimal inhibitory concentrations (MICs) of 32 µg/mL and 4 µg/mL, respectively. Compounds 1-2 showed stronger activity against S. aureus 209P than 3, which suggested a different structure-activity tendency against S. aureus from that of aldgamycins. This case indicated that 16-membered macrolide antibiotics with different sugars do not have parallel structure-activity relationships.
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